Health Condition 1: M148- Arthropathies in other specified diseases classified elsewhere
Conditions
Interventions
Intervention1: shallakyadi capsule: 2 capsules twice daily before meal with luke warm water orally for the duration of 8 weeks
Control Intervention1: Shallakyadi Capsule: 2 capsule twice a day before
Sponsors
Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar
Eligibility
Inclusion criteria
Inclusion criteria: Age between 18 years to 60 years of either sex. Confirm case of Chikungunya fever Patient willing to participate in the trial.
Exclusion criteria
Exclusion criteria: Age below 18 years & above 60 years. ? Pregnant and lactating women ? History of RA, Gout, Psoriatic arthritis, rheumatic fever, autoimmune disease, thyroid dysfunction, sarcoidosis, SLE before Chikungunya fever. ? Patients suffering from: Malignant and accelerated hypertension, coronary artery disease, uncontrolled diabetes. ? Patient undergoing regular treatment for any other severe illness and also patients suffering from pulmonary tuberculosis or bone tuberculosis, carcinoma and HIV positive patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the trial drug will reduce the inflammation and pain through correcting underlined pathogenesis and so that it will become possible to prevent Post-Chikungunya Chronic Inflammatory Rheumatism (pCHIK-CIR).Timepoint: at the end of 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The drug will improve the quality of life in patient of Chikungunya.Timepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactBineesh E P
Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar
Outcome results
None listed